For example, novo Nordisk is also advancing cagrilintide as standalone treatment
FOXO4-DRI is a D-retro-inverso peptide built from a FOXO4 fragment that binds p53, joined to a cell-penetrating sequence, with a molecular weight near 4.8 kDa
But it has a more stable metabolic byproduct that can serve as a marker for it and which is reportedly detectable for 48 to 72 hours
[DOI] [PMC free article] [PubMed] [Google Scholar] 180.Sucic M., Luetic K., Jandric I., Drmic D., Sever A.Z., Vuletic L.B., Halle Z.B., Strinic D., Kokot A., Seiwerth R.S., et al
346 Ultimately, integrating molecular biophysics into rehabilitation not only improves our understanding of recovery processes but also enables the development of more effective, personalized treatment strategies that address individual needs and conditions